Form Q7B is derived from the guidelines (Good Manufacturing Practice for Active Pharmaceutical Ingredients) and has been adapted by the SFDA to suit local regulatory requirements.
Cross-border commercial transactions between corporate entities in the Kingdom of Saudi Arabia (KSA) and international businesses require strict adherence to local tax compliance. Under domestic tax law, Saudi entities must deduct Withholding Tax (WHT) on gross payments made to non-resident service providers, royalties, dividends, or international debt claims. However, to foster global trade and protect companies from paying duplicate levies, Saudi Arabia has built an expansive network of Double Taxation Avoidance Agreements (DTAAs) with over 55 global jurisdictions.
A "verified" or "authenticated" Form Q7B ensures that a non-resident beneficiary can benefit from reduced withholding tax (WHT) rates at the source rather than paying the full rate and seeking a refund later. form q7b saudi arabia verified
Achieving verification requires careful data compilation and submission through official channels. 1. Gather Required Documents
“You, Baba,” she said. “I wrote your name at the bottom.” Form Q7B is derived from the guidelines (Good
ZATCA requires these applications to be submitted within five years of the tax period, but doing it proactively prevents audits and penalties.
If approved, the GHAD system issues a digitally signed with a unique registration number and expiration date (typically 3 to 5 years). However, to foster global trade and protect companies
Secure a Tax Residency Certificate (TRC) from the tax authority in your home country.
| Income Type | Standard Saudi WHT Rate | Treaty Rate Under UAE-KSA DTT | Saving | |---|---|---|---| | Royalties | 15% | Reduced rate negotiated under treaty | Significant reduction | | Interest | 15% | Reduced rate negotiated under treaty | Significant reduction | | Technical Fees | 15% | Reduced rate negotiated under treaty | Significant reduction | | Dividends | 15% | Reduced rate negotiated under treaty | Significant reduction |
is an official submission document required by the Saudi Food and Drug Authority (SFDA) for the registration of pharmaceutical products, specifically active pharmaceutical ingredients (APIs) and certain finished pharmaceutical products (FPPs). The term “Saudi Arabia Verified” indicates that the information declared in Form Q7B has been authenticated, cross-checked, and accepted by the SFDA as part of the drug registration or GMP compliance process.